Nebraska 2025 Session Status: To Executive

LB77 — The official site of the Nebraska Unicameral Legislature

Last action — Provisions/portions of LB253 amended into LB77 by AM1187

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Legislature
  4. 4
    To Executive
  5. 5
    Enacted

This bill has been sent to the executive. Introduced January 09, 2025. It awaits signature.

Signed by Governor Jim Pillen (Republican) on May 30, 2025.

Next likely step: the executive signs it into law or issues a veto.

Prognosis

Advancing 42% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • To Executive

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

Adopt the Ensuring Transparency in Prior Authorization Act and provide for insurance and medicaid coverage of biomarker testing

Bill Text

We don't have the full text on file for this bill yet.

Read LB77 on the official Nebraska source →

Action History

  1. Date of introduction

  2. Referred to Banking, Commerce and Insurance Committee

  3. Notice of hearing for February 10, 2025

  4. Speaker priority bill

  5. Placed on General File with AM1187

  6. Banking, Commerce and Insurance AM1187 filed

  7. Bostar AM1261 to AM1187 filed

  8. Bostar AM1261 adopted

  9. Banking, Commerce and Insurance AM1187 adopted

  10. Advanced to Enrollment and Review Initial

  11. Placed on Select File with ER86

  12. Enrollment and Review ER86 filed

  13. Enrollment and Review ER86 adopted

  14. Advanced to Enrollment and Review for Engrossment

  15. Placed on Final Reading

  16. Dispensing of reading at large approved

  17. Passed on Final Reading 46-2*-1

  18. President/Speaker signed

  19. Presented to Governor on May 30, 2025

  20. Approved by Governor on June 4, 2025

  21. Provisions/portions of LB253 amended into LB77 by AM1187

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 48 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (48)

48 members have not signed on to this bill.

Show all 48 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does LB77 do?
Adopt the Ensuring Transparency in Prior Authorization Act and provide for insurance and medicaid coverage of biomarker testing
Who sponsors LB77?
LB77 is sponsored by Eliot Bostar.
What is the current status of LB77?
This bill has been sent to the executive. Introduced January 09, 2025. It awaits signature.
Where can I track LB77?
Track LB77 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on LB77

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of LB77

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →